Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Latest useless interview , YEARS AWAY FROM RESULTS !
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(113)
•••
Comment by JohnnyRingo20on Nov 11, 2022 9:03am
70 Views
Post# 35090953

RE:Latest useless interview , YEARS AWAY FROM RESULTS !

RE:Latest useless interview , YEARS AWAY FROM RESULTS !

SamV21 wrote: Once again Golddetector/ crapdetector do you actually watch anything you post ? they have proven nothing to date , years of more research and testing , thousands of people and 100,000s of millions of dollars MORE to prove anything .Tetra is broke and no one else wants to fund Guys dreams anymore after he scammed investors out of millions , this interview does nothing for Tetra but proves they are no further along than they were in 2018 when Guy started milking the company ! How can you believe any of the garbage they post any more ? Where is all the revenue Guy promised investors since 2019 ?? STOP TRYING TO SUCK OTHERS INTO THIS SCAM SO GUY CAN MOVE MORE MONEY INTO HIS PRIVATELY HELD INC. NUMBERED COMPANY .


that's why I asked him for cliff notes. I didn't see anything but fluff so stopped watching. 


im 100% sure TBP is doing nothing but collecting pay checks. 
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities